Lifelong genetically lowered sclerostin and risk of cardiovascular disease

類似資料

• Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics
  著者:: Bovijn, J, 等
  出版事項: (2020)
• Response to comment on “Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics”
  著者:: Bovijn, J, 等
  出版事項: (2021)
• Causal relevance of obesity on the leading causes of death in women and men: A Mendelian randomization study
  著者:: Censin, JC, 等
  出版事項: (2019)
• Causal relationships between obesity and the leading causes of death in women and men
  著者:: Censin, JC, 等
  出版事項: (2019)
• Commentary: Mendelian randomization and women's health
  著者:: Censin, JC, 等
  出版事項: (2019)